Falls and fractures in men with prostate cancer taking second-generation androgen receptor antagonists: A retrospective chart review
Journal of Oncology Pharmacy Practice
Published online on October 22, 2024
Abstract
Journal of Oncology Pharmacy Practice, Volume 32, Issue 3, Page 472-478, April 2026.
IntroductionSecond-generation androgen receptor antagonists, including enzalutamide, apalutamide, and darolutamide, are commonly used to treat metastatic and non-metastatic prostate cancer. Although these medications are typically well-tolerated, falls ...
IntroductionSecond-generation androgen receptor antagonists, including enzalutamide, apalutamide, and darolutamide, are commonly used to treat metastatic and non-metastatic prostate cancer. Although these medications are typically well-tolerated, falls ...